Ossio raises $27.6M for orthofix implant commercialization

Ossio raised $27.6 million in equity funding to accelerate commercialization of its Ossiofiber surgical implants, the company said Dec. 2.

Advertisement

Questa Capital led the funding round, and existing investors also participated. The money will scale all aspects of commercialization including a new product pipeline, sales channel and medical education, according to a news release. Ossio will also build a flagship U.S. manufacturing site and surgeon training in Florida.

Ossiofiber implants provide fixation without metal and bone in-growth, regeneration and replacement. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.